These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. US and European postmarket clinical data requirements. Donawa M Med Device Technol; 2005 Mar; 16(2):19-21. PubMed ID: 15828495 [TBL] [Abstract][Full Text] [Related]
11. EU and US clinical investigation adverse event reporting. Crowley G Med Device Technol; 2004 Jun; 15(5):30-2. PubMed ID: 15285486 [TBL] [Abstract][Full Text] [Related]
12. Encoding technical information in GM organisms. Marillonnet S; Klimyuk V; Gleba Y Nat Biotechnol; 2003 Mar; 21(3):224-6. PubMed ID: 12610560 [No Abstract] [Full Text] [Related]
13. [Sanitary control of cosmetics]. Bonini M; Pellino P; Pilla M Ig Sanita Pubbl; 2005; 61(3):271-84. PubMed ID: 17206194 [TBL] [Abstract][Full Text] [Related]
17. The Safe Medical Devices Act. Williams MA South Hosp; 1992; 58(2):16-7. PubMed ID: 10118188 [TBL] [Abstract][Full Text] [Related]
18. IOM panel hears concerns about U.S. drug safety system. Young D Am J Health Syst Pharm; 2005 Jul; 62(14):1428, 1430-31. PubMed ID: 15998915 [No Abstract] [Full Text] [Related]
19. The need for human data: the role of clinical trials and postmarketing surveillance in the safety assessment of macronutrient substitutes. Forbes AL Regul Toxicol Pharmacol; 1996 Feb; 23(1 Pt 2):S20-1; discussion S31-7. PubMed ID: 8801611 [TBL] [Abstract][Full Text] [Related]
20. European drug regulation--anti-protectionism or consumer protection? Lancet; 1991 Jun; 337(8757):1571-2. PubMed ID: 1675711 [No Abstract] [Full Text] [Related] [Next] [New Search]